文献速递肿瘤 PET/CT

18F-FFNP检测乳腺癌雌激素刺激后孕激素受体蛋白变化的敏感性与亚型特异性

Sensitivity and Isoform Specificity of 18F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer.
PubMed 文献 · J Nucl Med · 2018-07-20

本研究在T47D乳腺癌细胞及小鼠移植瘤中评估18F-FFNP测量雌二醇刺激后孕激素受体(PR)蛋白水平及亚型表达变化的能力。结果显示,雌二醇处理48和72小时后细胞摄取较对照及24小时处理显著增加,72小时移植瘤摄取达11.3±1.4 %ID/g(对照5.2±0.81 %ID/g,P=0.002),且PR-A与PR-B亚型间未见 preferential 结合或摄取差异。

要点

  • 雌二醇处理48和72小时后T47D细胞18F-FFNP摄取较对照及24小时处理显著增加。
  • 72小时雌二醇处理小鼠移植瘤18F-FFNP摄取为11.3±1.4 %ID/g,对照为5.2±0.81 %ID/g(P=0.002)。
  • PR-A与PR-B亚型特异性细胞系及移植瘤中18F-FFNP结合或摄取无显著优先差异。

核心结论

  • 18F-FFNP能够测量人乳腺癌细胞和肿瘤移植瘤中雌激素诱导的总PR表达变化,且亚型结合等效。

研究设计与样本

  • 研究使用T47D人乳腺癌细胞及雌性小鼠T47D肿瘤移植瘤,以17β-雌二醇(E2)处理以增加PR表达。
  • 通过细胞摄取实验和组织生物分布实验测量18F-FFNP摄取。
  • 构建表达人PR-A或PR-B亚型的MDA-MB-231乳腺癌克隆细胞系,测定PR蛋白水平、转录功能及亚细胞定位。
  • 通过饱和与竞争结合曲线测量体外18F-FFNP结合,通过肿瘤移植瘤和正电子发射断层显像测量体内18F-FFNP摄取。
  • 统计学显著性采用方差分析和t检验确定。

主要发现

  • E2处理48和72小时后,T47D细胞18F-FFNP摄取较溶剂对照(p<0.0001 vs 乙醇)及24小时E2处理(48小时P=0.02,72小时P=0.0002)最大程度增加。
  • 72小时E2处理小鼠T47D移植瘤18F-FFNP摄取较乙醇处理小鼠最大,为11.3±1.4 vs 5.2±0.81 %ID/g(P=0.002)。
  • 48小时E2、72小时E2和乙醇处理小鼠的肿瘤/肌肉摄取比分别为4.1±0.6、3.9±0.5和2.3±0.4。
  • PR亚型特异性细胞系和肿瘤移植瘤中,PR-A与PR-B对18F-FFNP的结合或摄取无显著优先差异。

关键数值与推荐

  • T47D细胞E2处理48和72小时后18F-FFNP摄取较24小时处理增加,48小时P=0.02,72小时P=0.0002。
  • 72小时E2处理小鼠移植瘤18F-FFNP摄取11.3±1.4 %ID/g vs 乙醇对照5.2±0.81 %ID/g,P=0.002。
  • 肿瘤/肌肉摄取比:48小时E2为4.1±0.6,72小时E2为3.9±0.5,乙醇对照为2.3±0.4。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The purpose of this study was to evaluate the ability of 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione (18F-FFNP) to measure alterations in progesterone receptor (PR) protein level and isoform expression in response to estradiol challenge. Methods: T47D human breast cancer cells and female mice-bearing T47D tumor xenografts were treated with 17β-estradiol (E2) to increase PR expression. 18F-FFNP uptake was measured using cell uptake and tissue biodistribution assays. MDA-MB-231 breast cancer clonal cell lines were generated that express the A or B isoforms of human PR. PR protein levels, transcriptional function, and subcellular localization were determined. In vitro 18F-FFNP binding was measured via saturation and competitive binding curves. In vivo 18F-FFNP uptake was measured using tumor xenografts and positron emission tomography. Statistical significance was determined using analysis of variance and t-tests. Results: After 48 and 72 h of E2, 18F-FFNP uptake in T47D cells was maximally increased compared to both vehicle and 24 h E2 treatment (p<0.0001 vs ethanol; P = 0.02 and P = 0.0002 vs 24 h for 48 and 72 h, respectively). T47D tumor xenografts in mice treated with 72 h E2 had maximal 18F-FFNP uptake compared to ethanol-treated mice (11.3±1.4 vs 5.2±0.81 %ID/g; P = 0.002). Corresponding tumor-to-muscle uptake ratios were 4.1±0.6, 3.9±0.5, and 2.3±0.4 for 48 h E2, 72 h E2, and ethanol-treated mice, respectively. There was no significant preferential 18F-FFNP binding or uptake by PR-A versus PR-B in the PR isoform-specific cell lines and tumor xenografts. Conclusion:18F-FFNP is capable of measuring estrogen-induced shifts in total PR expression in human breast cancer cells and tumor xenografts with equivalent isoform binding.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Salem K, Kumar M, Yan Y, et al. Sensitivity and Isoform Specificity of 18F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer. J Nucl Med. 2018. PMID: 30030339. doi:10.2967/jnumed.118.211516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。